- Home
- UMBF vs CORT Comparison
UMBF vs CORT Comparison
Compare UMBF & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UMBF
- CORT
- Stock Information
- Founded
- UMBF 1913
- CORT 1998
- Country
- UMBF United States
- CORT United States
- Employees
- UMBF N/A
- CORT N/A
- Industry
- UMBF Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- UMBF Finance
- CORT Health Care
- Exchange
- UMBF Nasdaq
- CORT Nasdaq
- Market Cap
- UMBF 8.2B
- CORT 7.6B
- IPO Year
- UMBF N/A
- CORT N/A
- Fundamental
- Price
- UMBF $109.56
- CORT $78.94
- Analyst Decision
- UMBF Buy
- CORT Strong Buy
- Analyst Count
- UMBF 11
- CORT 4
- Target Price
- UMBF $136.27
- CORT $139.00
- AVG Volume (30 Days)
- UMBF 508.2K
- CORT 784.5K
- Earning Date
- UMBF 10-28-2025
- CORT 11-04-2025
- Dividend Yield
- UMBF 1.57%
- CORT N/A
- EPS Growth
- UMBF 10.98
- CORT N/A
- EPS
- UMBF 8.89
- CORT 0.87
- Revenue
- UMBF $2,217,071,000.00
- CORT $741,172,000.00
- Revenue This Year
- UMBF $68.75
- CORT $28.85
- Revenue Next Year
- UMBF $7.86
- CORT $34.98
- P/E Ratio
- UMBF $12.34
- CORT $89.75
- Revenue Growth
- UMBF 45.52
- CORT 17.92
- 52 Week Low
- UMBF $82.00
- CORT $49.00
- 52 Week High
- UMBF $129.94
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- UMBF 45.05
- CORT 56.28
- Support Level
- UMBF $109.11
- CORT $70.74
- Resistance Level
- UMBF $108.47
- CORT $77.01
- Average True Range (ATR)
- UMBF 2.64
- CORT 3.43
- MACD
- UMBF 0.37
- CORT 0.72
- Stochastic Oscillator
- UMBF 53.06
- CORT 92.13
About UMBF UMB Financial Corporation
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.